Similar articles

• Subcutaneous desferrioxamine in homozygous beta-thalassaemia.

  Silvestroni E, Bianco I, Graziani B, Carboni C, Costantini S. Silvestroni E, et al. Lancet. 1978 Nov 25;2(8100):1149-50. doi: 10.1016/s0140-6736(78)92302-4. Lancet. 1978. PMID: 82705 No abstract available.
• Iron chelation therapy with deferoxamine in Cooley anemia.

  Cohen A, Schwartz E. Cohen A, et al. J Pediatr. 1978 Apr;92(4):643-7. doi: 10.1016/s0022-3476(78)80314-x. J Pediatr. 1978. PMID: 633031
• The management of iron chelation therapy.

  Pippard MJ, Callender ST. Pippard MJ, et al. Br J Haematol. 1983 Aug;54(4):503-7. doi: 10.1111/j.1365-2141.1983.tb02128.x. Br J Haematol. 1983. PMID: 6871105 No abstract available.
• Desferrioxamine: its use in iron chelation in thalassemia.

  Sharma BK, Choudhury P, Dubey AP. Sharma BK, et al. Indian Pediatr. 1990 Mar;27(3):314-9. Indian Pediatr. 1990. PMID: 2190932 Review. No abstract available.
• Objectives and mechanism of iron chelation therapy.

  Hershko C, Link G, Konijn AM, Cabantchik ZI. Hershko C, et al. Ann N Y Acad Sci. 2005;1054:124-35. doi: 10.1196/annals.1345.015. Ann N Y Acad Sci. 2005. PMID: 16339658 Review.